Gemfibrozil Tablet
Product Images NDC 75834-131

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Gemfibrozil (NDC 75834-131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gemfibrozil 01)

The provided text seems to be a partial chemical formula containing some elements such as carbon (C), hydrogen (H), and carboxylic acid (COOH). However, the formula is incomplete and does not provide enough information to identify the compound or molecule it represents. Therefore, it is not possible to provide a useful description with such limited information.*

FDA Label Image

Principal Display Panel (600 mg Tablet Bottle Label)

This is a description of Gemfibrozil Tablets, USP, a medication used to reduce cholesterol levels. It contains 60 tablets, each coated with 600mg of gemfibrozil. The tablets should be stored at a controlled room temperature and protected from light and humidity. The usual dosage is included in the package insert. The medication is manufactured by Cadila Pharmaceuticals Ltd. in India and distributed by Nivagen Pharmaceuticals in Sacramento, CA. The NDC number is 75834-131-60.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.